Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
eIMPACT Trial
NCT02458690Phase 2Completed
- Sponsor
- Indiana University
- Start
- Jul 2015
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in major depressive disorder (MDD) and cardiovascular disease (CVD) (2 arms), sponsored by Indiana University. Primary endpoint: Brachial Artery Flow-Mediated Dilation at 12 months. Started Jul 2015; status: completed.
02
Conditions
major depressive disorder (MDD)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02458690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02458690.